Reviewed,
UniProtKB/Swiss-Prot Q13557 (KCC2D_HUMAN)
Last modified
February 9, 2010.
Version 109.
History...
Clusters with 100%,
90%,
50% identity |
Documents (7) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Calcium/calmodulin-dependent protein kinase type II subunit delta Short name=CaM kinase II subunit delta Short name=CaMK-II subunit delta EC=2.7.11.17 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Complete proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 499 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | CaM-kinase II (CAMK2) is a prominent kinase in the central nervous system that may function in long-term potentiation and neurotransmitter release. |
| Catalytic activity | ATP + a protein = ADP + a phosphoprotein. |
| Enzyme regulation | Autophosphorylation of CAMK2 plays an important role in the regulation of the kinase activity. |
| Subunit structure | CAMK2 is composed of four different chains: alpha, beta, gamma, and delta. The different isoforms assemble into homo- or heteromultimeric holoenzymes composed of 8 to 12 subunits. Interacts with RRAD By similarity. |
| Tissue specificity | Expressed in cardiac muscle and skeletal muscle. Isoform Delta 3, isoform Delta 2, isoform Delta 8 and isoform Delta 9 are expressed in cardiac muscle. Isoform Delta 11 is expressed in skeletal muscle. Ref.1 |
| Miscellaneous | Expression of CAMK2D is significantly increased in patients suffering from dilated cardiomyopathy. |
| Sequence similarities | Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family. CaMK subfamily. Contains 1 protein kinase domain. |
Ontologies
| Keywords | |
|---|---|
| Coding sequence diversity | Alternative splicing Polymorphism |
| Ligand | ATP-binding Calmodulin-binding Nucleotide-binding |
| Molecular function | Kinase Serine/threonine-protein kinase Transferase |
| PTM | Acetylation Phosphoprotein |
| Technical term | 3D-structure Complete proteome |
| Gene Ontology (GO) | |
| Biological process | regulation of cell growth Ref.6 Non-traceable author statement. Source: UniProtKB |
| Cellular component | calcium- and calmodulin-dependent protein kinase complex Traceable author statement. Source: UniProtKB cytosolInferred from Experiment. Source: Reactome endocytic vesicle membraneInferred from Experiment. Source: Reactome nucleoplasmInferred from Experiment. Source: Reactome |
| Molecular function | ATP binding Non-traceable author statement. Source: UniProtKB calmodulin bindingInferred from electronic annotation. Source: UniProtKB-KW calmodulin-dependent protein kinase activityInferred from electronic annotation. Source: EC |
| Complete GO annotation... | |
Alternative products
| This entry describes 9 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform Delta 2 (identifier: Q13557-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform Delta 3 (identifier: Q13557-3) The sequence of this isoform differs from the canonical sequence as follows: 328-328: K → KKRKSSSSVQMM | ||||||
| Isoform Delta 4 (identifier: Q13557-4) The sequence of this isoform differs from the canonical sequence as follows: 328-328: K → KINNKANVVTSPKENIPTPAL | ||||||
| Isoform Delta 6 (identifier: Q13557-8) The sequence of this isoform differs from the canonical sequence as follows: 479-499: Missing. | ||||||
| Isoform Delta 7 (identifier: Q13557-9) The sequence of this isoform differs from the canonical sequence as follows: 328-328: K → KKRKSSSSVQMM 479-499: Missing. | ||||||
| Isoform Delta 8 (identifier: Q13557-5) The sequence of this isoform differs from the canonical sequence as follows: 328-328: K → KINNKANVVTSPKENIPTPAL 479-499: Missing. | ||||||
| Isoform Delta 9 (identifier: Q13557-6) The sequence of this isoform differs from the canonical sequence as follows: 329-329: E → EPQTTVIHNPDGNKE | ||||||
| Isoform Delta 10 (identifier: Q13557-10) The sequence of this isoform differs from the canonical sequence as follows: 329-329: E → EPQTTVIHNPDGNKE 479-499: Missing. | ||||||
| Isoform Delta 11 (identifier: Q13557-11) The sequence of this isoform differs from the canonical sequence as follows: 328-328: K → KKRKSSSSVQMMEPQTTVIHNPDGNK |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Chain | 2 – 499 | 498 | Calcium/calmodulin-dependent protein kinase type II subunit delta | PRO_0000086099 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 14 – 272 | 259 | Protein kinase | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Nucleotide binding | 20 – 28 | 9 | ATP By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Region | 291 – 301 | 11 | Calmodulin-binding By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Active site | 136 | 1 | Proton acceptor By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 43 | 1 | ATP By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 2 | 1 | N-acetylalanine Ref.12 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 3 | 1 | Phosphoserine Ref.9 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 231 | 1 | Phosphotyrosine By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 287 | 1 | Phosphothreonine | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 306 | 1 | Phosphothreonine | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 307 | 1 | Phosphothreonine | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 315 | 1 | Phosphoserine Ref.9 Ref.8 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 319 | 1 | Phosphoserine Ref.9 Ref.8 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 330 | 1 | Phosphoserine Ref.10 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 331 | 1 | Phosphothreonine Ref.9 Ref.10 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 333 | 1 | Phosphoserine Ref.12 Ref.10 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 334 | 1 | Phosphoserine | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 336 | 1 | Phosphothreonine | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 337 | 1 | Phosphothreonine Ref.8 Ref.10 Ref.7 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 404 | 1 | Phosphoserine | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 441 | 1 | Phosphoserine | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 470 | 1 | Phosphoserine | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 472 | 1 | Phosphoserine Ref.9 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 490 | 1 | Phosphoserine | |||||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 328 | 1 | K → KKRKSSSSVQMMEPQTTVIH NPDGNK in isoform Delta 11. | VSP_023095 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 328 | 1 | K → KKRKSSSSVQMM in isoform Delta 3 and isoform Delta 7. | VSP_023096 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 328 | 1 | K → KINNKANVVTSPKENIPTPA L in isoform Delta 4 and isoform Delta 8. | VSP_023097 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 329 | 1 | E → EPQTTVIHNPDGNKE in isoform Delta 9 and isoform Delta 10. | VSP_023098 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 479 – 499 | 21 | Missing in isoform Delta 6, isoform Delta 7, isoform Delta 8 and isoform Delta 10. | VSP_023099 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 167 | 1 | D → E: dbSNP rs35367671. Ref.14 | VAR_040602 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 463 | 1 | Q → E: dbSNP rs1053668. | VAR_028196 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 493 | 1 | T → I: dbSNP rs35765784. Ref.14 | VAR_040603 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 39 | 1 | E → G in AAD20442. Ref.1 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 272 | 1 | I → T in AAX88806. Ref.3 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 14 – 19 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 26 – 34 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 39 – 45 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 47 – 49 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 52 – 67 | 16 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 76 – 81 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 86 – 90 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 98 – 105 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 110 – 129 | 20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 139 – 141 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 142 – 147 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 153 – 155 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 183 – 186 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 194 – 199 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 203 – 208 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 219 – 227 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 235 – 240 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 243 – 252 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 257 – 259 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 263 – 266 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 270 – 273 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 296 – 300 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 304 – 315 | 12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Identification and expression of delta-isoforms of the multifunctional Ca2+/calmodulin-dependent protein kinase in failing and nonfailing human myocardium." Hoch B., Meyer R., Hetzer R., Krause E.-G., Karczewski P. Circ. Res. 84:713-721(1999) [PubMed: 10189359] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM DELTA 2), ALTERNATIVE SPLICING, TISSUE SPECIFICITY. Tissue: Myocardium. |
| [2] | Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S., Ohara O., Nagase T., Kikuno R.F. Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM DELTA 10). Tissue: Brain. |
| [3] | Zhou G., Nong W., Li H., Ke R., Li M., Zheng Z., Zhong G., Shen C., Liang M., Lin L., Yang S. Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM DELTA 7). |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM DELTA 6). |
| [5] | "Cloning and quantitative determination of the human Ca2+/calmodulin-dependent protein kinase II (CaMK II) isoforms in human beta cells." Rochlitz H., Voigt A., Lankat-Buttgereit B., Goeke B., Heimberg H., Nauck M.A., Schiemann U., Schatz H., Pfeiffer A.F. Diabetologia 43:465-473(2000) [PubMed: 10819240] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-243, ALTERNATIVE SPLICING. Tissue: Insulinoma. |
| [6] | "Identification of novel human tumor cell-specific CaMK-II variants." Tombes R.M., Krystal G.W. Biochim. Biophys. Acta 1355:281-292(1997) [PubMed: 9060999] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 302-417, ALTERNATIVE SPLICING. |
| [7] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-337, MASS SPECTROMETRY. Tissue: Epithelium. |
| [8] | "Proteomics analysis of protein kinases by target class-selective prefractionation and tandem mass spectrometry." Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R., Keri G., Wehland J., Daub H. Mol. Cell. Proteomics 6:537-547(2007) [PubMed: 17192257] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-315; SER-319 AND THR-337, MASS SPECTROMETRY. |
| [9] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed: 18691976] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3; SER-315; SER-319; THR-331 AND SER-472, MASS SPECTROMETRY. |
| [10] | "Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography." Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D., Zou H., Gu J. Proteomics 8:1346-1361(2008) [PubMed: 18318008] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-330; THR-331; SER-333 AND THR-337, MASS SPECTROMETRY. Tissue: Liver. |
| [11] | Colinge J., Superti-Furga G., Bennett K.L. Submitted (OCT-2008) to UniProtKB Cited for: IDENTIFICATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY. |
| [12] | "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach." Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S. Anal. Chem. 81:4493-4501(2009) [PubMed: 19413330] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-333, MASS SPECTROMETRY. |
| [13] | "Large-scale proteomics analysis of the human kinome." Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H. Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed: 19369195] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3; THR-287; THR-306; THR-307; SER-315; SER-319; SER-330; THR-331; SER-333; SER-334; THR-336; THR-337; SER-404; SER-441; SER-470; SER-472 AND SER-490, MASS SPECTROMETRY. |
| [14] | "Patterns of somatic mutation in human cancer genomes." Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G. Stratton M.R.Nature 446:153-158(2007) [PubMed: 17344846] [Abstract] Cited for: VARIANTS [LARGE SCALE ANALYSIS] GLU-167 AND ILE-493. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AF071569 mRNA. Translation: AAD20442.1. AB209288 mRNA. Translation: BAD92525.1. Different initiation. AY987011 mRNA. Translation: AAX88806.1. BC032784 mRNA. Translation: AAH32784.1. AJ252239 mRNA. Translation: CAB65123.1. U50361 mRNA. Translation: AAB16866.1. | ||||||||||||||||||||||||
| IPI | IPI00172636. IPI00430291. IPI00654569. IPI00827573. IPI00827606. IPI00827625. IPI00827717. IPI00828139. IPI00828178. | ||||||||||||||||||||||||
| RefSeq | NP_001212.2. NP_742112.1. NP_742113.1. NP_742125.1. NP_742126.1. NP_742127.1. | ||||||||||||||||||||||||
| UniGene | Hs.144114 | ||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||
| IntAct | Q13557. 11 interactions. | ||||||||||||||||||||||||
| STRING | Q13557. | ||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||
| PhosphoSite | Q13557. | ||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||
| PRIDE | Q13557. | ||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||
| Ensembl | ENST00000342666; ENSP00000339740; ENSG00000145349; Homo sapiens. [Genome view] | ||||||||||||||||||||||||
| GeneID | 817. | ||||||||||||||||||||||||
| KEGG | hsa:817. | ||||||||||||||||||||||||
| UCSC | uc003ibi.1. human. uc003ibk.1. human. uc003ibm.1. human. uc003ibn.1. human. | ||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||
| CTD | 817. | ||||||||||||||||||||||||
| GeneCards | GC04M114655. | ||||||||||||||||||||||||
| HGNC | HGNC:1462. CAMK2D. | ||||||||||||||||||||||||
| HPA | HPA026281. | ||||||||||||||||||||||||
| MIM | 607708. gene. | ||||||||||||||||||||||||
| PharmGKB | PA92. | ||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||
| eggNOG | prNOG15150. | ||||||||||||||||||||||||
| HOGENOM | HBG755340. | ||||||||||||||||||||||||
| HOVERGEN | Q13557. | ||||||||||||||||||||||||
| InParanoid | Q13557. | ||||||||||||||||||||||||
| PhylomeDB | Q13557. | ||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||
| BRENDA | 2.7.11.17. 247. | ||||||||||||||||||||||||
| Pathway_Interaction_DB | ifngpathway. IFN-gamma pathway. | ||||||||||||||||||||||||
| Reactome | REACT_13685. Synaptic Transmission. | ||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||
| ArrayExpress | Q13557. | ||||||||||||||||||||||||
| Bgee | Q13557. | ||||||||||||||||||||||||
| CleanEx | HS_CAMK2D. | ||||||||||||||||||||||||
| Genevestigator | Q13557. | ||||||||||||||||||||||||
| GermOnline | ENSG00000145349. Homo sapiens. | ||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||
| InterPro | IPR020636. Ca/CaM-dep_prot_kinase-like. IPR015742. Ca/CaM-dep_prot_kinase_2. IPR011009. Kinase-like_dom. IPR000719. Prot_kinase_cat_dom. IPR017441. Protein_kinase_ATP_BS. IPR017442. Se/Thr_prot_kinase-like_dom. IPR008271. Ser/Thr_prot_kinase_AS. IPR002290. Ser/Thr_prot_kinase_dom. [Graphical view] | ||||||||||||||||||||||||
| PANTHER | PTHR22982. Ca/CaM-dep_prot_kinase-like. 1 hit. PTHR22982:SF64. CaMKII. 1 hit. | ||||||||||||||||||||||||
| Pfam | PF00069. Pkinase. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| SMART | SM00220. S_TKc. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| PROSITE | PS00107. PROTEIN_KINASE_ATP. 1 hit. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00108. PROTEIN_KINASE_ST. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||
Other Resources | |||||||||||||||||||||||||
| NextBio | 3330. | ||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||
Entry information
| Entry name | KCC2D_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q13557 Secondary accession number(s): Q52PK4 Q9UQE9 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 4 Human chromosome 4: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| Human and mouse protein kinases Human and mouse protein kinases: classification and index |
| SIMILARITY comments Index of protein domains and families |

Clusters with


